Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors by Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, Susanne D. Nielsen

Get full text

Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions by Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, Susanne D. Nielsen

Get full text

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART). by Sanne Skov Jensen, Anders Fomsgaard, Marie Borggren, Jeanette Linnea Tingstedt, Jan Gerstoft, Gitte Kronborg, Line Dahlerup Rasmussen, Court Pedersen, Ingrid Karlsson

Get full text

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon. by Andrew E Armitage, Koen Deforche, Chih-Hao Chang, Edmund Wee, Beatrice Kramer, John J Welch, Jan Gerstoft, Lars Fugger, Andrew McMichael, Andrew Rambaut, Astrid K N Iversen

Get full text

Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort Study by Moises Alberto Suarez-Zdunek, Andreas Dehlbæk Knudsen, Andreas Fuchs, Nikolai Søren Kirkby, Thomas Benfield, Jan Gerstoft, Marius Trøseid, Sisse Rye Ostrowski, Lars Valeur Køber, Klaus Fuglsang Kofoed, Susanne Dam Nielsen

Get full text

Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations. by Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T Røge, Suzanne Lunding, Toke S Barfod, Lone G Madsen, Britta Tarp, Peer B Christensen, Jan Gerstoft, Alex L Laursen, Jens Bukh, Nina Weis, DANHEP group

Get full text